Skip to main content

Crossject closes €15m equity raise to advance ZEPIZURE EUA process Signati Medical wins FDA IDE approval for Separo vasectomy device trial Senseonics presents real-world Eversense 365 data at ADA 2026 Biomea Fusion presents icovamenib diabetes data at ADA 2026 Cullinan Therapeutics' CLN-978 shows remissions in SLE and RA at EULAR Cloudbreak Pharma completes final visits for Phase 3 pterygium trial Structure Therapeutics' aleniglipron data published in Nature Medicine InnoCare orelabrutinib hits Phase IIb endpoints in SLE study Memo Therapeutics presents Phase II data on potravitug for BKPyV SynCardia's Emperor TAH completes next-gen preclinical implant series BioCardia wins FDA backing for single-trial PMA path for CardiAMP Fractyl Health: Revita holds 78% of GLP-1 weight loss at one year Zealand Pharma petrelintide hits 10.7% weight loss at 42 weeks Hengrui and Kailera report ribupatide Phase 2 oral data at ADA 2026 Chiesi wins EC approval for lomitapide in children with HoFH Crossject closes €15m equity raise to advance ZEPIZURE EUA process Signati Medical wins FDA IDE approval for Separo vasectomy device trial Senseonics presents real-world Eversense 365 data at ADA 2026 Biomea Fusion presents icovamenib diabetes data at ADA 2026 Cullinan Therapeutics' CLN-978 shows remissions in SLE and RA at EULAR Cloudbreak Pharma completes final visits for Phase 3 pterygium trial Structure Therapeutics' aleniglipron data published in Nature Medicine InnoCare orelabrutinib hits Phase IIb endpoints in SLE study Memo Therapeutics presents Phase II data on potravitug for BKPyV SynCardia's Emperor TAH completes next-gen preclinical implant series BioCardia wins FDA backing for single-trial PMA path for CardiAMP Fractyl Health: Revita holds 78% of GLP-1 weight loss at one year Zealand Pharma petrelintide hits 10.7% weight loss at 42 weeks Hengrui and Kailera report ribupatide Phase 2 oral data at ADA 2026 Chiesi wins EC approval for lomitapide in children with HoFH

Search

Sign in Create account

Subscribe

Main navigation

News
Sectors
Content
- Analysis
- Interview
- Opinion
- Podcast
- Video
- Webinar
Events
Newsletter
About
Contact

Breadcrumb

Home
Contact

Contact

Your Name

Your Email

Subject

Message

Subscribe to The Biotech Times

Email

The subscriber's email address.

Manage your newsletter subscriptions

Biotech Times — Daily Briefing

Biotech Times — Event Alerts

Biotech Times — Monthly Report

Biotech Times — Weekly Sector Digest

Select the newsletter(s) to which you want to subscribe.

Get the biotech news that matters — pick the briefings that suit you.

Sectors you’re interested in

Pick as many as you like — your digest will lead with stories from these sectors. Leave blank if you want everything.

Manage existing

Legal

Privacy Policy
Cookie Policy
Terms of Use
Acceptable Use Policy (Community Guidelines)
Copyright & Takedown Policy
Accessibility Statement

Editorial

AI Use Policy
Editorial Standards & Corrections Policy
Why we ask for your business email
Sponsored Content & Advertising Disclosure

© 2026 Disrupts Media Limited · Company No. 09447878

Registered office: 41 Luke Street, London EC2A 4DP, United Kingdom

hello@disruptsmedia.com · privacy@disruptsmedia.com